The importance of antibody dependent cell-mediated cytotoxicity (ADCC) for breast cancer response to trastuzumab - Herceptin
In this work we investigated the direct or indirect (through ADCC) cytotoxic action of Herceptin, to two breast carcinoma cell lines: to MDA-MB 361, for HER-2, IHC score (3+) and to MDA-MB 453, IHC score (<2+). Cytotoxic action of Herceptin, of PBMC and of their combination (ADCC) was determi...
Main Authors: | Juranić Zorica D., Stanojević-Bakić Nevenka, Nešković-Konstantinović Zora, Žižak Željko, Stanojković Tatjana, Radulović Siniša S., Milošević Dušanka |
---|---|
Format: | Article |
Language: | English |
Published: |
Institute of Oncology, Sremska Kamenica, Serbia
2002-01-01
|
Series: | Archive of Oncology |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0354-7310/2002/0354-73100203162J.pdf |
Similar Items
-
Radiation Recall Reaction Induced by Adjuvant Trastuzumab (Herceptin)
by: Caroline Chung, et al.
Published: (2009-01-01) -
Validation of ELISA Test-system for Trastuzumab (Herceptin, Hertikad) quantitative determination in biological fluids
by: V. V. Pisarev, et al.
Published: (2023-05-01) -
Chemotherapy-induced cardiotoxic effect in breast cancer patients treated with trastuzumab (Herceptin) by MRI
by: Mohamed Aboulfotouh Mourad, et al.
Published: (2023-12-01) -
Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer
by: Caroline Muñoz, et al.
Published: (2024-03-01) -
Investigation of combined action of Cis-DDP and irradiation to HeLa cells in vitro
by: Čikarić Slobodan, et al.
Published: (2002-01-01)